Judith Bhatt

Judith Bhatt contributes to retinoblastoma research and treatment — a pediatric eye cancer caused by biallelic RB1 inactivation. Intraarterial chemotherapy has revolutionized retinoblastoma treatment, enabling eye salvage in many patients who previously required enucleation. Research on optimizing intraocular and systemic treatment to preserve vision, prevent metastatic disease, and minimize late effects in retinoblastoma addresses important goals in this curable pediatric cancer.